These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2935791)

  • 1. The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cells.
    Pollard M; Luckert PH
    Prostate; 1986; 8(1):81-6. PubMed ID: 2935791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diphosphonate and x-rays on bone lesions induced in rats by prostate cancer cells.
    Pollard M; Luckert PH; Scheu J
    Cancer; 1988 May; 61(10):2027-32. PubMed ID: 2965968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells.
    Pollard M; Luckert PH
    J Natl Cancer Inst; 1985 Nov; 75(5):949-54. PubMed ID: 2932588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between natural killer cells and drugs that modify metastasis of PA-III cells.
    Tazume S; Pollard M
    Cancer Lett; 1985 Dec; 29(3):323-9. PubMed ID: 2934126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of post-extraction alveolar ridge resorption in rats by dichloromethane diphosphonate.
    Olson HM; Hagen A
    J Periodontal Res; 1982 Nov; 17(6):669-74. PubMed ID: 6219214
    [No Abstract]   [Full Text] [Related]  

  • 6. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.
    Elte JW; Bijvoet OL; Cleton FJ; van Oosterom AT; Sleeboom HP
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):493-500. PubMed ID: 2942409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis.
    Flora L
    Arthritis Rheum; 1979 Apr; 22(4):340-6. PubMed ID: 154893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia and hypercalcemia: treatment with dichloromethylene diphosphonate.
    Siris ES; Grossbard L; Halper JP; Blume RS; Jacobs TP
    Metab Bone Dis Relat Res; 1983-1984; 5(2):61-3. PubMed ID: 6231452
    [No Abstract]   [Full Text] [Related]  

  • 11. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dichloromethylene diphosphonate in the treatment of lytic bone metastases].
    Chantraine A; Jung A; van Ouwenaller C; Donath A
    Presse Med; 1984 Feb; 13(8):479-82. PubMed ID: 6230629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in prostate carcinoma.
    Adami S
    Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates.
    Sun YC; Geldof AA; Newling DW; Rao BR
    J Urol; 1992 Oct; 148(4):1270-3. PubMed ID: 1404658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.
    Adami S; Salvagno G; Guarrera G; Bianchi G; Dorizzi R; Rosini S; Mobilio G; Lo Cascio V
    J Urol; 1985 Dec; 134(6):1152-4. PubMed ID: 2932559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice.
    Nemoto R; Sato S; Nishijima Y; Miyakawa I; Koiso K; Harada M
    J Urol; 1990 Sep; 144(3):770-4. PubMed ID: 2117674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
    Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
    Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.